A step by step approach in differential diagnosing of adrenal incidentaloma (epinephroma), (with comments on the new Clinical Practice Guidelines of the European Society of Endocrinology)

Farrugia, Frederick-Anthony; Misiakos, Evangelos; Martikos, Georgios; Tzanetis, Panagiotis; Charalampopoulos, Anestis; Zavras, Nicolaos; Sotiropoulos, Dimitrios; Koliakos, Nikolaos

doi:10.1515/rjim-2017-0025

References

1. UDELSMAN R. ADRENAL. In: Norton A J, Bollinger RR, editors. Surgery, Basic Science and Clinical Evidence: Springer; 2001, p. 902.
Search in Google Scholar Back to article
2. BULOW B, JANSSON S, JUHLIN C, STEEN L, THOREN M, WAHRENBERG H, et al. Adrenal incidentaloma – follow-up results from a Swedish prospective study. Eur J Endocrinol 2006; 154 (3):419-23.10.1530/eje.1.0211016498055
Search in Google Scholar Back to article
3. ANAGNOSTIS P, KARAGIANNIS A, TZIOMALOS K, KAKAFIKA AI, ATHYROS VG, MIKHAILIDIS DP. Adrenal incidentaloma: a diagnostic challenge. Hormones (Athens) 2009; 8 (3):163-84.10.14310/horm.2002.123319671516
Search in Google Scholar Back to article
4. GRUMBACH MM, BILLER BM, BRAUNSTEIN GD, CAMPBELL KK, CARNEY JA, GODLEY PA, et al. Management of the clinically inapparent adrenal mass (adrenal incidentaloma). Annals of Internal Medicine 2003; 138 (5):424-429.10.7326/0003-4819-138-5-200303040-0001312614096
Search in Google Scholar Back to article
5. FASSNACHT M, ARLT W, BANCOS I, DRALLE H, NEWELL-PRICE J, SAHDEV A, et al. Management of adrenal incidentalomas: European society of endocrinology clinical practice guideline in collaboration with the European network for the study of adrenal tumors. European Journal of Endocrinology 2016; 175 (2):G1-G34.10.1530/EJE-16-046727390021
Search in Google Scholar Back to article
6. PAPIERSKA L, CICHOCKI A, SANKOWSKI AJ, CWIKLA JB. Adrenal incidentaloma imaging - the first steps in therapeutic management. Pol J Radiol 2013; 78 (4):47-55.10.12659/PJR.889541390850724505223
Search in Google Scholar Back to article
7. LINOS DA. Adrenal incidentaloma (adrenaloma). Hormones (Athens) 2003; 2 (1):12-21.10.14310/horm.2002.117817002998
Search in Google Scholar Back to article
8. GEELHOED GW, DRUY EM. Management of the adrenal “incidentaloma”. Surgery 1982; 92 (5):866-74.
Search in Google Scholar Back to article
9. GOVE PB. Webster’s third new international dictionary of the English language, unabridged: Merriam-Webster; 2002.
Search in Google Scholar Back to article
10. FARRUGIA FA, MARTIKOS G, TZANETIS P, ZAVRAS N, CHARALAMPOPOULOS A, SOTIROPOULOS D, et al. Adrenal incidentaloma or epinephroma and review of the literature. Differential Diagnosis of Adrenal Incidentaloma. Khirurgiia 2016; October (3):120-129.
Search in Google Scholar Back to article
11. DIVRY DBC. English-Greek and Greek English Handy Dictionary. In Revised Edition ed. New York: D.C. Divry, Inc., Publishers; 1994, p. 326.
Search in Google Scholar Back to article
12. WARDA MHA, SHEHATA SM, ZAITON F. Chemical-shift MRI versus washout CT for characterizing adrenal incidentalomas. Clinical Imaging 2016; 40 (4):780-787.10.1016/j.clinimag.2016.02.00627317224
Search in Google Scholar Back to article
13. YIP L, TUBLIN ME, FALCONE JA, NORDMAN CR, STANG MT, OGILVIE JB, et al. The adrenal mass: correlation of histopathology with imaging. Annals of surgical oncology 2010; 17 (3):846-852.10.1245/s10434-009-0829-219960266
Search in Google Scholar Back to article
14. SEO JM, PARK BK, PARK SY, KIM CK. Characterization of lipid-poor adrenal adenoma: chemical-shift MRI and washout CT. American Journal of Roentgenology 2014; 202 (5):1043-1050.10.2214/AJR.13.1138924758658
Search in Google Scholar Back to article
15. SCHIEDA N, SIEGELMAN ES. Update on CT and MRI of Adrenal Nodules. American Journal of Roentgenology 2017:1-12.10.2214/AJR.16.1775828225653
Search in Google Scholar Back to article
16. ZEIGER MA, THOMPSON GB, DUH Q-Y, HAMRAHIAN AH, ANGELOS P, ELARAJ D, et al. American Association of Clinical Endocrinologists and American Association of Endocrine Surgeons medical guidelines for the management of adrenal incidentalomas. Endocrine Practice 2009; 15:1-20.10.4158/EP.15.S1.1
Search in Google Scholar Back to article
17. DEFECHEREUX T, DEGAUQUE C, HAMOIR E, LAMBERTY G, PREUD’HOMME L, MEURISSE M. [Discordance between actual and radiologically estimated size of an incidentaloma. Delay in questions regarding operative decision-making criteria]. Ann Chir 2002; 127 (2):126-9.10.1016/S0003-3944(01)00705-2
Search in Google Scholar Back to article
18. PAPIERSKA L, CICHOCKI A, SANKOWSKI AJ, CWIKLA JB. Adrenal incidentaloma imaging – the first steps in therapeutic management. Pol J Radiol; 78 (4):47-55.10.12659/PJR.889541390850724505223
Search in Google Scholar Back to article
19. REGINELLI A, DI GREZIA G, IZZO A, DΒ€™ANDREA A, GATTA G, CAPPABIANCA S, et al. Imaging of adrenal incidentaloma: Our experience. International Journal of Surgery 2014; 12:S126-S131.10.1016/j.ijsu.2014.05.02924862667
Open DOI Search in Google Scholar Back to article
20. MORELLI V, SCILLITANI A, AROSIO M, CHIODINI I. Follow-up of patients with adrenal incidentaloma, in accordance with the European Society of Endocrinology guidelines: Could we be safe? Journal of Endocrinological Investigation 2016:1-3.10.1007/s40618-016-0558-x27744612
Search in Google Scholar Back to article
21. CHIODINI I, ALBANI A, AMBROGIO AG, CAMPO M, DE MARTINO MC, MARCELLI G, et al. Six controversial issues on subclinical Cushing’s syndrome. Endocrine 2016:1-5.10.1007/s12020-016-1017-327406391
Search in Google Scholar Back to article
22. CHIODINI I, MORELLI V. Subclinical hypercortisolism: how to deal with it? In: Cortisol Excess and Insufficiency: Karger Publishers; 2016, 28-38.10.1159/00044386227212038
Search in Google Scholar Back to article
23. PAPIERSKA L, CICHOCKI A, SANKOWSKI AJ, CWIKLA JB. Adrenal incidentaloma imaging-the first steps in therapeutic management. Polish Journal of Radiology 2013; 78 (4):47.10.12659/PJR.889541
Search in Google Scholar Back to article
24. MANTERO F, TERZOLO M, ARNALDI G, OSELLA G, MASINI AM, ALI A, et al. A survey on adrenal incidentaloma in Italy. Study Group on Adrenal Tumors of the Italian Society of Endocrinology. J Clin Endocrinol Metab 2000; 85 (2):637-44.
Search in Google Scholar Back to article
25. TABUCHI Y, OTSUKI M, KASAYAMA S, KOSUGI K, HASHIMOTO K, YAMAMOTO T, et al. Clinical and endocrinological characteristics of adrenal incidentaloma in Osaka region, Japan. Endocrine journal 2015 (0).
Search in Google Scholar Back to article
26. SONG JH, GRAND DJ, BELAND MD, CHANG KJ, MACHAN JT, MAYO-SMITH WW. Morphologic features of 211 adrenal masses at initial contrast-enhanced CT: can we differentiate benign from malignant lesions using imaging features alone? American Journal of Roentgenology 2013; 201 (6):1248-1253.
Search in Google Scholar Back to article
27. ILIAS I, SAHDEV A, REZNEK RH, GROSSMAN AB, PACAK K. The optimal imaging of adrenal tumours: a comparison of different methods. Endocrine-Related Cancer 2007; 14 (3):587-599.10.1677/ERC-07-004517914090
Search in Google Scholar Back to article
28. DUNNICK NR, KOROBKIN M. Imaging of adrenal incidentalomas: current status. American Journal of Roentgenology 2002; 179 (3):559-568.10.2214/ajr.179.3.179055912185019
Search in Google Scholar Back to article
29. LOCKHART ME, SMITH JK, KENNEY PJ. Imaging of adrenal masses. European journal of radiology 2002; 41 (2):95-112.10.1016/S0720-048X(01)00444-2
Open DOI Search in Google Scholar Back to article
30. YOUNG JR WF. The incidentally discovered adrenal mass. New England Journal of Medicine 2007; 356 (6):601-610.10.1056/NEJMcp06547017287480
Search in Google Scholar Back to article
31. ZEIGER MA, SIEGELMAN SS, HAMRAHIAN AH. Medical and surgical evaluation and treatment of adrenal incidentalomas. The Journal of Clinical Endocrinology & Metabolism 2011; 96 (7):2004-2015.10.1210/jc.2011-008521632813
Open DOI Search in Google Scholar Back to article
32. MANSMANN G, LAU J, BALK E, ROTHBERG M, MIYACHI Y, BORNSTEIN SR. The clinically inapparent adrenal mass: update in diagnosis and management. Endocrine reviews 2004; 25 (2):309-340.10.1210/er.2002-003115082524
Open DOI Search in Google Scholar Back to article
33. BEDNARCZUK T, BOLANOWSKI M, SWORCZAK K, GORNICKA B, CIESZANOWSKI A, OTTO M, et al. Adrenal incidentaloma in adults’ management recommendations by the Polish Society of Endocrinology. Endokrynologia Polska 2016; 67 (2):234.10.5603/EP.a2016.003927082051
Search in Google Scholar Back to article
34. FRANCIS IR. Distinguishing benign from malignant adrenal masses. Cancer Imaging 2015; 3 (2):102.
Search in Google Scholar Back to article
35. MAYO-SMITH W, LEE M, MCNICHOLAS M, HAHN P, BOLAND G, SAINI S. Characterization of adrenal masses (< 5 cm) by use of chemical shift MR imaging: observer performance versus quantitative measures. AJR. American Journal of Roentgenology 1995; 165 (1):91-95.10.2214/ajr.165.1.77856427785642
Search in Google Scholar Back to article
36. BILBEY JH, MCLOUGHLIN R, KURKJIAN P, WILKINS G, CHAN N, SCHMIDT N, et al. MR imaging of adrenal masses: value of chemical-shift imaging for distinguishing adenomas from other tumors. AJR. American Journal of Roentgenology 1995; 164 (3):637-642.10.2214/ajr.164.3.78638857863885
Search in Google Scholar Back to article
37. MIYAKE H, MAEDA H, TASHIRO M, SUZUKI K, NAGATOMO H, AIKAWA H, et al. CT of adrenal tumors: frequency and clinical significance of low-attenuation lesions. American Journal of Roentgenology 1989; 152 (5):1005-1007.10.2214/ajr.152.5.10052705336
Search in Google Scholar Back to article
38. BLAKE MA, KRISHNAMOORTHY SK, BOLAND GW, SWEENEY AT, PITMAN MB, HARISINGHANI M, et al. Lowdensity pheochromocytoma on CT: a mimicker of adrenal adenoma. American Journal of Roentgenology 2003; 181 (6):1663-1668.10.2214/ajr.181.6.181166314627592
Search in Google Scholar Back to article
39. ARNALDI G, MASINI A, GIACCHETTI G, TACCALITI A, FALOIA E, MANTERO F. Adrenal incidentaloma. Brazilian Journal of Medical and Biological Research 2000; 33 (10):1177-1189.10.1590/S0100-879X2000001000007
Search in Google Scholar Back to article
40. LOU I, SCHNEIDER DF, LEVERSON GE, SIPPEL RS, CHEN H. Do additional imaging studies change operative management in patients undergoing adrenalectomy? Surgery 2015; 158 (4):1003-1011.
Search in Google Scholar Back to article
41. NIH state-of-the-science statement on management of the clinically inapparent adrenal mass (“incidentaloma”). NIH Consens State Sci Statements 2002; 19 (2):1-25.
Search in Google Scholar Back to article
42. BOLAND GW, BLAKE MA, HAHN PF, MAYO-SMITH WW. Incidental Adrenal Lesions: Principles, Techniques, and Algorithms for Imaging Characterization 1. Radiology 2008; 249 (3):756-775.10.1148/radiol.249307097619011181
Search in Google Scholar Back to article
43. MAYO-SMITH WW, BOLAND GW, NOTO RB, LEE MJ. State-of-the-art adrenal imaging. Radiographics 2001; 21 (4):995-1012.10.1148/radiographics.21.4.g01jl2199511452074
Open DOI Search in Google Scholar Back to article
44. LEE JK. Computed body tomography with MRI correlation: Lippincott Williams & Wilkins, 1998.
Search in Google Scholar Back to article
45. KRESTIN GP, STEINBRICH W, FRIEDMANN G. Adrenal masses: evaluation with fast gradient-echo MR imaging and Gd-DTPA-enhanced dynamic studies. Radiology 1989; 171 (3):675-680.10.1148/radiology.171.3.27177372717737
Search in Google Scholar Back to article
46. CONDER G, RENDLE J, KIDD S, MISRA RR. AZ of Abdominal Radiology. Cambridge University Press; 2009. p. 28-37.10.1017/CBO9780511575792
Search in Google Scholar Back to article
47. SCHTEINGART D, DOHERTY G, GAUGER P, GIORDANO T, HAMMER G, KOROBKIN M, et al. Management of patients with adrenal cancer: recommendations of an international consensus conference. Endocrine-Related Cancer 2005; 12 (3):667-680.10.1677/erc.1.0102916172199
Open DOI Search in Google Scholar Back to article
48. ELSAYES KM, MUKUNDAN G, NARRA VR, LEWIS JR JS, SHIRKHODA A, FAROOKI A, et al. Adrenal Masses: MR Imaging Features with Pathologic Correlation 1. Radiographics 2004; 24 (suppl_1):S73-S86.10.1148/rg.24si04551415486251
Open DOI Search in Google Scholar Back to article
49. FIEBRICH H-B, BROUWERS AH, KERSTENS MN, PIJL ME, KEMA IP, DE JONG JR, et al. 6-[F-18] Fluoro-L-dihydroxyphenylalanine positron emission tomography is superior to conventional imaging with 123I-metaiodobenzylguanidine scintigraphy, computer tomography, and magnetic resonance imaging in localizing tumors causing catecholamine excess. The Journal of Clinical Endocrinology & Metabolism 2009; 94 (10):3922-3930.10.1210/jc.2009-105419622618
Search in Google Scholar Back to article
50. SUNDIN A. Imaging of adrenal masses with emphasis on adrenocortical tumors. Theranostics 2012; 2 (5):516-22.10.7150/thno.3613336455722737189
Search in Google Scholar Back to article
51. Dorland. Dorland’s Illustrated Medical Dictionary. 32 ed: Saunders, 2007.
Search in Google Scholar Back to article
52. LENDERS JW, PACAK K, WALTHER MM, LINEHAN WM, MANNELLI M, FRIBERG P, et al. Biochemical diagnosis of pheochromocytoma: which test is best? Jama 2002; 287 (11):1427-1434.
Search in Google Scholar Back to article
53. IACOBONE M, CITTON M, SCARPA M, VIEL G, BOSCARO M, NITTI D. Systematic review of surgical treatment of subclinical Cushing’s syndrome. British Journal of Surgery 2015; 102 (4):318-330.10.1002/bjs.974225640696
Search in Google Scholar Back to article
54. THOMAS AZ, BLUTE ML, SEITZ C, HABRA MA, KARAM JA. Management of the incidental adrenal mass. European Urology Focus 2016; 1 (3):223-230.10.1016/j.euf.2015.12.00628723391
Search in Google Scholar Back to article
55. FUNDER JW, CAREY RM, FARDELLA C, GOMEZ-SANCHEZ CE, MANTERO F, STOWASSER M, et al. Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline. The Journal of Clinical Endocrinology & Metabolism 2008; 93 (9):3266-3281.10.1210/jc.2008-010418552288
Open DOI Search in Google Scholar Back to article
56. CALHOUN DA, JONES D, TEXTOR S, GOFF DC, MURPHY TP, TOTO RD, et al. Resistant hypertension: diagnosis, evaluation, and treatment. Circulation 2008; 117 (25):e510-e526.10.1161/CIRCULATIONAHA.108.18914118574054
Search in Google Scholar Back to article
57. MATTSSON C, YOUNG WF. Primary aldosteronism: diagnostic and treatment strategies. Nature Clinical Practice Nephrology 2006; 2 (4):198-208.10.1038/ncpneph015116932426
Open DOI Search in Google Scholar Back to article
58. YOUNG WF, JR. Minireview: primary aldosteronism--changing concepts in diagnosis and treatment. Endocrinology 2003; 144 (6):2208-13.10.1210/en.2003-027912746276
Search in Google Scholar Back to article
59. YOUNG JR WF. Adrenalectomy for primary aldosteronism; authors’ reply. Ann Intern Med 2003; 138:157-159.10.7326/0003-4819-138-2-200301210-00024
Search in Google Scholar Back to article
60. EISENHOFER G, LENDERS JW, LINEHAN WM, WALTHER MM, GOLDSTEIN DS, KEISER HR. Plasma normeta-nephrine and metanephrine for detecting pheochromocytoma in von Hippel-Lindau disease and multiple endocrine neoplasia type 2. New England Journal of Medicine 1999; 340 (24):1872-1879.10.1056/NEJM19990617340240410369850
Search in Google Scholar Back to article
61. GALATI S-J, SAID M, GOSPIN R, BABIC N, BROWN K, GEER EB, et al. The mount Sinai clinical pathway for the management of pheochromocytoma. Endocrine Practice 2014; 21 (4):368-382.10.4158/EP14036.RA25297659
Open DOI Search in Google Scholar Back to article
62. FRANCIS IR, GROSS MD, SHAPIRO B, KOROBKIN M, QUINT L. Integrated imaging of adrenal disease. Radiology 1992; 184 (1):1-13.10.1148/radiology.184.1.16090631609063
Search in Google Scholar Back to article
63. FRANCIS IR, KOROBKIN M, BRODEUR FJ, YUTZY GG, QUINT LE, DUNNICK NR, et al. Pheochromocytoma Differentiation of adrenal adenomas from nonadenomas using CT attenuation values. Radiol Clin North Am 1996; 34 (6):1101-12.10.1016/S0033-8389(22)00693-5
Search in Google Scholar Back to article
64. EISENHOFER G, GOLDSTEIN DS, WALTHER MM, FRIBERG P, LENDERS JW, KEISER HR, et al. Biochemical diagnosis of pheochromocytoma: how to distinguish true-from false-positive test results. The Journal of Clinical Endocrinology & Metabolism 2003; 88 (6):2656-2666.10.1210/jc.2002-03000512788870
Open DOI Search in Google Scholar Back to article
65. VAN BERKEL A, LENDERS J, TIMMERS H. Diagnosis of endocrine Disease: Biochemical diagnosis of phaeochromocytoma and paraganglioma. European Journal of Endocrinology 2014; 170 (3):R109-R119.10.1530/EJE-13-088224347425
Search in Google Scholar Back to article
66. MAUREA S, CUOCOLO A, REYNOLDS J, NEUMANN R, SALVATORE M. Diagnostic imaging in patients with paragangliomas. Computed tomography, magnetic resonance and MIBG scintigraphy comparison. The quarterly journal of nuclear medicine: official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR) 1996; 40 (4):365-371.
Search in Google Scholar Back to article
67. RABER W, RAFFESBERG W, BISCHOF M, SCHEUBA C, NIEDERLE B, GASIC S, et al. Diagnostic efficacy of unconjugated plasma metanephrines for the detection of pheochromocytoma. Archives of Internal Medicine 2000; 160 (19):2957-2963.10.1001/archinte.160.19.295711041903
Search in Google Scholar Back to article
68. MITTENDORF EA, EVANS DB, LEE JE, PERRIER ND. Pheochromocytoma: advances in genetics, diagnosis, localization, and treatment. Hematology/oncology clinics of North America 2007; 21 (3):509-525.10.1016/j.hoc.2007.04.01217548037
Open DOI Search in Google Scholar Back to article
69. YOUNG WF. Primary aldosteronism: renaissance of a syndrome. Clinical endocrinology 2007; 66 (5):607-618.10.1111/j.1365-2265.2007.02775.x17492946
Search in Google Scholar Back to article
70. SAWKA AM, JAESCHKE R, SINGH RJ, YOUNG JR WF. A comparison of biochemical tests for pheochromocytoma: measurement of fractionated plasma metanephrines compared with the combination of 24-hour urinary metanephrines and catecholamines. The Journal of Clinical Endocrinology & Metabolism 2003; 88 (2):553-558.10.1210/jc.2002-02125112574179
Open DOI Search in Google Scholar Back to article
71. JOHNSON PT, HORTON KM, FISHMAN EK. Adrenal Mass Imaging with Multidetector CT: Pathologic Conditions, Pearls, and Pitfalls 1. Radiographics 2009; 29 (5):1333-1351.10.1148/rg.29509502719755599
Open DOI Search in Google Scholar Back to article
72. MARINI F, FALCHETTI A, DEL MONTE F, CARBONELL SALA S, TOGNARINI I, LUZI E, et al. Multiple endocrine neoplasia type 2. Orphanet J Rare Dis 2006; 1 (45):4.
Search in Google Scholar Back to article
73. ERLIC Z, NEUMANN HP. Familial pheochromocytoma. Hormones (Athens) 2009; 8 (1):29-38.10.14310/horm.2002.121919269919
Search in Google Scholar Back to article
74. National Institutes of Health Consensus Development Conference Statement: neurofibromatosis. Bethesda, Md., USA, July 13-15, 1987. Neurofibromatosis 1988; 1 (3):172-8.
Search in Google Scholar Back to article
75. HERR K, MUGLIA VF, KOFF WJ, WESTPHALEN AC. Imaging of the adrenal gland lesions. Radiologia brasileira 2014; 47 (4):228-239.10.1590/0100-3984.2013.1762433712325741090
Search in Google Scholar Back to article
76. BARZON L, SCARONI C, SONINO N, FALLO F, PAOLETTA A, BOSCARO M. Risk factors and long-term follow-up of adrenal incidentalomas. J Clin Endocrinol Metab 1999; 84 (2):520-6.10.1210/jc.84.2.520
Search in Google Scholar Back to article
77. MORELLI V, REIMONDO G, GIORDANO R, DELLA CASA S, POLICOLA C, PALMIERI S, et al. Long-term follow-up in adrenal incidentalomas: an Italian multicenter study. The Journal of Clinical Endocrinology & Metabolism 2014; 99 (3):827-834.10.1210/jc.2013-352724423350
Search in Google Scholar Back to article
78. LOPEZ D, LUQUE-FERNANDEZ MA, STEELE A, ADLER GK, TURCHIN A, VAIDYA A. “Nonfunctional” Adrenal Tumors and the Risk for Incident Diabetes and Cardiovascular Outcomes. A Cohort Study “Nonfunctional” Adrenal Tumors and Risk for Incident Diabetes. Annals of internal medicine 2016; 165 (8):533-542.10.7326/M16-0547545363927479926
Search in Google Scholar Back to article
79. PAPANASTASIOU L, ALEXANDRAKI KI, ANDROULAKIS, II, FOUNTOULAKIS S, KOUNADI T, MARKOU A, et al. Concomitant alterations of metabolic parameters, cardiovascular risk factors and altered cortisol secretion in patients with adrenal incidentalomas during prolonged follow-up. Clin Endocrinol (Oxf); 86 (4):488-498.10.1111/cen.13294
Search in Google Scholar Back to article
80. SALCUNI AS, MORELLI V, VAINICHER CE, PALMIERI S, CAIROLI E, SPADA A, et al. Adrenalectomy reduces the risk of vertebral fractures in patients with monolateral adrenal incidentalomas and subclinical hypercortisolism. European Journal of Endocrinology 2016; 174 (3):261-269.10.1530/EJE-15-0977
Search in Google Scholar Back to article
81. TUNA MM, IMGA NN, DOGAN BA, YILMAZ FM, TOPCUOGLLU C, AKBABA G, et al. Non-functioning adrenal incidentalomas are associated with higher hypertension prevalence and higher risk of atherosclerosis. Journal of endocrinological investigation 2014; 37 (8):765-768.10.1007/s40618-014-0106-5
Search in Google Scholar Back to article
82. YE Y-L, YUAN X-X, CHEN M-K, DAI Y-P, QIN Z-K, ZHENG F-F. Management of adrenal incidentaloma: the role of adrenalectomy may be underestimated. BMC surgery 2016; 16 (1):41.10.1186/s12893-016-0154-1
Search in Google Scholar Back to article
83. FONTANA D, PORPIGLIA F, DESTEFANIS P, FIORI C, ALI A, TERZOLO M, et al. What is the role of ultrasonography in the follow-up of adrenal incidentalomas? Urology 1999; 54 (4):612-616.10.1016/S0090-4295(99)00226-5
Open DOI Search in Google Scholar Back to article
84. MULATERO, P., RABBIA F, MILAN A, PAGLIERI C, MORELLO F, CHIANDUSSI L, VEGLIO F. Drug effects on aldosterone/plasma renin activity ratio in primary aldosteronism. Hypertension 2002; 40 (6):897-902.10.1161/01.HYP.0000038478.59760.4112468576
Open DOI Search in Google Scholar Back to article

A step by step approach in differential diagnosing of adrenal incidentaloma (epinephroma), (with comments on the new Clinical Practice Guidelines of the European Society of Endocrinology)

References

Paradigm

My account